News Sentiment

GMAB sentiment intelligence

Genmab AS news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 59 Balanced news tone 56 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 29.00 Week of 10 Jul 2026
Weighted tone 59/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

75/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+1.7% over one week, +15.6% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Analysts Are Bullish on Top Healthcare Stocks: Chemomab Therapeutics (CMMB), Genmab (GMAB)

Market Reaction

Balanced read

67/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 75/100 classification
One-week reaction 1.7% Price digesting
Trend fit Trend inactive 15.6% over four weeks
Fair value 6.0% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 20
Neutral 31
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 17
Stock Titan 5
GlobeNewswire 5
Investing.com 3
The Globe and Mail 2
MT Newswires 2
TradingView 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 21
Analyst action 7
Regulatory and legal 5

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-56 of 56